Memory chip shortage: How crazy could it get?
NEW YORK — SpaceX’s record-breaking initial public offering has thrust the aerospace pioneer into the public markets at a valuation exceeding $2 trillion, drawing intense investor...
This article was written by Follow Brett Ashcroft-Green, CFP® is a CERTIFIED FINANCIAL PLANNER™ professional and fee-only fiduciary. He is the owner and lead advisor at...
Agios presents detailed mitapivat trial results for sickle cell
This article was written by Follow Pythia Research focuses on multi-bagger stocks, primarily in the technology sector. Our approach combines financial analysis, behavioral finance, psychology, social...
Humanoid industrial robot are on display at the humanoid robot data training center in Shougang Park on March 27, 2025 in Beijing, China. VCG | China...
How SpaceX shares will trade today is anyone’s guess. But here’s a fun—if imperfect—guidepost: Tesla’s IPO. Tesla debuted on Nasdaq nearly 16 years ago. Back then,...
Drugmakers are only months into introducing GLP-1 pills and navigating huge changes in how patients pay for weight-loss drugs. Even so, they’re already outlining their visions...
Spencer Jakab | Double Trouble
Why an Iran deal might not be dovish for the Fed